Kyle Jenne, Chief Commercial Officer at AKCEA THERAPEUTICS, INC. (AKCA), sold 779 shares at $11.75 ($9K) on 2020-03-23, disclosed to the SEC on 2020-03-25.
Open-market sale of $9k AKCA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2026-01-20 | $138K | — | Filing → |
| IONS | SELL | 2025-04-17 | $171K | — | Filing → |
| AKCA | SELL | 2020-09-24 | $13K | — | Filing → |